PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation

Rasmus Sejersten Ripa; Sune Folke Pedersen; Andreas Kjær

doi:10.1016/j.cpet.2016.05.009

PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation

Rasmus Sejersten Ripa, Sune Folke Pedersen, Andreas Kjær

Endocrinology and Metabolism

2 Citations (Scopus)

Abstract

For imaging of atherosclerotic disease, lumenography using computed tomography, ultrasonography, or invasive angiography is still the backbone of evaluation. However, these methods are less effective to predict the likelihood of future thromboembolic events caused by vulnerability of plaques. PET and MR imaging have been used separately with success for plaque characterization. Where MR imaging has the ability to reveal plaque composition, PET has the ability to visualize plaque activity. Together this leads to a comprehensive evaluation of plaque vulnerability. In this review, the authors go through data and arguments that support increased use of PET/MR imaging in atherosclerotic imaging.

Original language	English
Journal	PET Clinics
Volume	11
Issue number	4
Pages (from-to)	479-488
Number of pages	10
ISSN	1556-8598
DOIs	https://doi.org/10.1016/j.cpet.2016.05.009
Publication status	Published - 1 Oct 2016

Keywords

Atherosclerosis
Humans
Inflammation
Magnetic Resonance Imaging
Multimodal Imaging
Positron-Emission Tomography
Vascular Diseases
Journal Article
Review

Access to Document

10.1016/j.cpet.2016.05.009

Cite this

@article{5133109cff044550958fe0cc688754e2,

title = "PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation",

abstract = "For imaging of atherosclerotic disease, lumenography using computed tomography, ultrasonography, or invasive angiography is still the backbone of evaluation. However, these methods are less effective to predict the likelihood of future thromboembolic events caused by vulnerability of plaques. PET and MR imaging have been used separately with success for plaque characterization. Where MR imaging has the ability to reveal plaque composition, PET has the ability to visualize plaque activity. Together this leads to a comprehensive evaluation of plaque vulnerability. In this review, the authors go through data and arguments that support increased use of PET/MR imaging in atherosclerotic imaging.",

keywords = "Atherosclerosis, Humans, Inflammation, Magnetic Resonance Imaging, Multimodal Imaging, Positron-Emission Tomography, Vascular Diseases, Journal Article, Review",

author = "Ripa, {Rasmus Sejersten} and Pedersen, {Sune Folke} and Andreas Kj{\ae}r",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.cpet.2016.05.009",

language = "English",

volume = "11",

pages = "479--488",

journal = "P E T Clinics",

issn = "1556-8598",

publisher = "W.B.Saunders Co.",

number = "4",

}

TY - JOUR

T1 - PET/MR Imaging in Vascular Disease

T2 - Atherosclerosis and Inflammation

AU - Ripa, Rasmus Sejersten

AU - Pedersen, Sune Folke

AU - Kjær, Andreas

PY - 2016/10/1

Y1 - 2016/10/1

N2 - For imaging of atherosclerotic disease, lumenography using computed tomography, ultrasonography, or invasive angiography is still the backbone of evaluation. However, these methods are less effective to predict the likelihood of future thromboembolic events caused by vulnerability of plaques. PET and MR imaging have been used separately with success for plaque characterization. Where MR imaging has the ability to reveal plaque composition, PET has the ability to visualize plaque activity. Together this leads to a comprehensive evaluation of plaque vulnerability. In this review, the authors go through data and arguments that support increased use of PET/MR imaging in atherosclerotic imaging.

AB - For imaging of atherosclerotic disease, lumenography using computed tomography, ultrasonography, or invasive angiography is still the backbone of evaluation. However, these methods are less effective to predict the likelihood of future thromboembolic events caused by vulnerability of plaques. PET and MR imaging have been used separately with success for plaque characterization. Where MR imaging has the ability to reveal plaque composition, PET has the ability to visualize plaque activity. Together this leads to a comprehensive evaluation of plaque vulnerability. In this review, the authors go through data and arguments that support increased use of PET/MR imaging in atherosclerotic imaging.

KW - Atherosclerosis

KW - Humans

KW - Inflammation

KW - Magnetic Resonance Imaging

KW - Multimodal Imaging

KW - Positron-Emission Tomography

KW - Vascular Diseases

KW - Journal Article

KW - Review

U2 - 10.1016/j.cpet.2016.05.009

DO - 10.1016/j.cpet.2016.05.009

M3 - Journal article

C2 - 27593251

SN - 1556-8598

VL - 11

SP - 479

EP - 488

JO - P E T Clinics

JF - P E T Clinics

IS - 4

ER -

PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation

Abstract

Keywords

Access to Document

Fingerprint

Cite this